We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Requests Endo Remove Opioid Painkiller Opana ER From the Market After Reports of Abuse
FDA Requests Endo Remove Opioid Painkiller Opana ER From the Market After Reports of Abuse
The FDA requested that Endo Pharmaceuticals voluntarily remove its opioid painkiller Opana ER from the market, saying its benefits may no longer outweigh its risks of abuse — the first time the agency has taken steps to remove a currently marketed opioid from sale.